Senior insider sale
Chief Technology Officer at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$204.8K
25K shares
What this filing means
HARMON CYRUS plans to sell 25K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $204.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/18/2025ACC: 0001959173-25-006106
DirectorOfficer· Chief Technology Officer
Since Nov 2020
25K
Shares to sell
$204.8K
Approx. market value
13.09K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Open Market Purchase
Cash
6/30/2014
3.09KFounders Shares
Compensation
3/20/2007
10KTotal acquired13.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2014 | Open Market Purchase Cash | 3.09K | — |
3/20/2007 | Founders Shares Compensation | 10K | — |
| Total | 13.09K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.91K
Market value
$15.5K
9/16/2025
—Completed
Units to sell
10K
Market value
$80.4K
9/16/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
13.09K
Market value
$109.0K
9/18/2025
Total
Units
25K
Value
$204.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/16/2025 | 1.91K | $15.5K | — | Completed |
9/16/2025 | 10K | $80.4K | — | Completed |
| Planned — Approximate Date | ||||
9/18/2025 | 13.09K | $109.0K | NASDAQ | Planned |
| Total | 25K | $204.8K | ||